Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of L-carnitine effect in fatty liver treatment in children
IRCT20170628034786N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Isfahan University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
levocarnitine
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT20170628034786N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170628034786N2.